Behaviors, symptoms, and outcomes of North American patients with autoimmune hepatitis during the COVID-19 pandemic
Vahin Vuppalanchi, Kayla Gelow, Kelsey Green, Raj Vuppalanchi, Craig Lammert
DOI: 10.1136/jim-2021-001871 Published 25 November 2021
Vahin Vuppalanchi
Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, Indiana, USA
Kayla Gelow
Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, Indiana, USA
Kelsey Green
Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, Indiana, USA
Raj Vuppalanchi
Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, Indiana, USA
Craig Lammert
Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, Indiana, USA
Submit a Response to This Article
No eLetters have been published for this article.
Behaviors, symptoms, and outcomes of North American patients with autoimmune hepatitis during the COVID-19 pandemic
Vahin Vuppalanchi, Kayla Gelow, Kelsey Green, Raj Vuppalanchi, Craig Lammert
Journal of Investigative Medicine Dec 2021, 69 (8) 1426-1433; DOI: 10.1136/jim-2021-001871
Behaviors, symptoms, and outcomes of North American patients with autoimmune hepatitis during the COVID-19 pandemic
Vahin Vuppalanchi, Kayla Gelow, Kelsey Green, Raj Vuppalanchi, Craig Lammert
Journal of Investigative Medicine Dec 2021, 69 (8) 1426-1433; DOI: 10.1136/jim-2021-001871